Why fasting glucose is the last number to move
Fasting glucose 92, HbA1c 5.5, everything inside range or close enough that nobody remarks. Six years later it reads 131. The panel was not wrong. It was reading the number the body defends hardest.
A man of forty-seven has his blood tested. His fasting glucose is 92 mg/dL, which is normal. His weight, blood pressure and blood fats are a little off, but nothing is flagged. He is told he is fine. He hears the same next year, and the year after. At fifty-three his fasting glucose reads 118, then 131. Now he has a diagnosis of type 2 diabetes.
What was his body doing through those six normal years? It was certainly not doing nothing.
This article explains why glucose is the last number to move. You will also learn which markers move earlier, and why those quiet years matter so much.
Why does glucose move last?
Your body defends its blood glucose fiercely. Too much sugar in the blood damages vessels, nerves and kidneys. Too little starves the brain. So the body holds glucose within a narrow band, almost whatever it takes.
The hormone that moves glucose out of the blood and into cells is called insulin. When cells start responding poorly to insulin, the pancreas simply makes more of it. Researchers call this weakened response insulin resistance. The extra insulin pushes glucose into cells anyway. The fasting glucose reading stays exactly where it was.
That extra effort is the real story, and it can go on for a decade. Glucose reads normal not because the system is healthy, but because it is working overtime. A normal fasting glucose means the pancreas is still keeping up. It does not prove that insulin is working normally.
A large British study called Whitehall II followed more than six thousand people for over a decade. In those who went on to develop type 2 diabetes, fasting glucose stayed almost flat for years. It rose steeply only in the last two to three years before diagnosis. Insulin had been working harder for at least five years before that. The pancreas raised its output to cover the gap, then began to falter.
Glucose moves last because it is defended hardest. By the time it moves, the system behind it is already failing. So which numbers speak sooner?
Which numbers change before glucose does?
None of these markers is exotic. Several already sit on standard blood panels.
Fasting insulin is the most direct measure of the effort behind a normal glucose. A low value alongside a normal glucose describes a system at rest. A value of fifteen or twenty alongside the same glucose describes a pancreas working flat out. Laboratory reference ranges for insulin are wide, because they were built from populations where insulin resistance is common. So a result inside the range is not automatically reassuring. Read the number itself, not just the flag.
There is also a simple calculation that combines the two values. It multiplies fasting glucose by fasting insulin and divides by a constant. Researchers call it HOMA-IR. It estimates how much insulin your body spends to hold a given glucose. It is an approximation, and it works best as a trend within one person over time. A rising HOMA-IR alongside a flat glucose is the hidden effort made visible.
Your cholesterol panel offers a clue too. Compare your triglycerides, a type of blood fat, with your HDL, often called the good cholesterol. When insulin runs high, the liver makes more triglycerides, and HDL tends to fall. So a rising ratio of triglycerides to HDL hints that resistance is building. It is a rough clue, not a finding.
What about a glucose reading taken two hours after a sugary drink? Doctors call this an oral glucose tolerance test. A normal result rules out less than it appears to. The body may have produced an enormous amount of insulin to earn that normal reading. Measuring insulin at the same time shows whether the body coped easily or expensively.
Two more clues are physical rather than blood tests. A waist that grows faster than overall weight suggests insulin has run high for a while. So does fat building up in the liver, seen on ultrasound or as a mildly raised liver enzyme.
None of these is a diagnosis on its own. Together they answer what glucose cannot. Is this body truly at rest, or working hard to look at rest?
One reading is a snapshot; two a year apart are a direction. For fasting insulin and HOMA-IR, the trend carries more weight than any single value. Assays differ between laboratories, and the quoted thresholds are conventions. A figure that has doubled while glucose has not moved says more than one result near a cutoff.
That leaves one question. Does any of this matter while glucose is still normal?
Are the quiet years harmless?
It is tempting to file all this away as academic. The glucose is normal, there is no diagnosis, so surely nothing follows.
That view treats high insulin as harmless, and it is not. Raised insulin travels with rising blood pressure, unhealthy blood fats, fat in the liver and higher heart risk, all while glucose still reads normal. It also travels with polycystic ovary syndrome, a common hormonal condition in women. The harm does not wait for the diagnosis.
Which is why the year something is noticed matters nearly as much as what is noticed.
What does catching it early change?
The levers that lower insulin demand are familiar. They include what and when you eat, how much muscle you carry and use, how well you sleep, and how much of the day you spend sitting. Catching the process early does not change which levers exist. It changes how far they can still move.
These levers do more while the pancreas is still coping. Act early, and the realistic outcome is a system that stays stable for many years. Markers drift back down, and risk falls with them. Once the pancreas gives way and glucose climbs, the same levers still help. Remission stays achievable for some people, but the room to move narrows.
Early recognition does not change the biology. It changes the timing, and timing decides whether the story is stability held for years or an established condition being managed. Same person, same body, eight years apart.
Proven: high insulin comes years before high glucose. Large studies that measured people repeatedly, including Whitehall II, show this clearly. Consistently observed, though not fully settled: raised fasting insulin travelling with high blood pressure, unhealthy blood fats and liver fat. Convention rather than evidence: the quoted cutoffs for fasting insulin and HOMA-IR come from particular populations. They work best as a trend within one person, not as a line separating well from unwell.
- Glucose is defended hardest and moves last. A normal fasting glucose means the pancreas is keeping up, not that insulin is working normally.
- Fasting insulin and HOMA-IR measure the effort behind the glucose. Their cutoffs are conventions, so the trend beats the single value.
- A normal two-hour glucose can be earned by an outsized insulin response, so it rules out less than it seems.
- Raised insulin carries risk of its own while the glucose still looks fine.
Where this goes next is the single fasting insulin result. The units can make results look absurd, and even an accurate value can mislead. The field’s knowledge check will show how much has settled.
- Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-2221.
- DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773-795.
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
- McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine. 2003;139(10):802-809.
- Kraft JR. Detection of diabetes mellitus in situ (occult diabetes). Laboratory Medicine. 1975;6(2):10-22.
- Crofts C, Schofield G, Zinn C, Wheldon M, Kraft J. Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: an examination of the Kraft database. Diabetes Research and Clinical Practice. 2016;118:50-57.
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
This article is educational and does not replace individual medical advice. Reference thresholds vary by laboratory and population; read every marker in the context of the whole person.
Deep DiveFasting insulin: what it tells you, and when it liesHow to read a fasting insulin and a HOMA-IR properly: the units that make results absurd, what the arithmetic actually means, why the thresholds are conventions rather than cutoffs, the four traps that make an accurate value mislead, and the honest limits of what follows from a raised result.